Literature DB >> 20828570

Paired NK cell receptors controlling NK cytotoxicity.

Noa Stanietsky1, Ofer Mandelboim.   

Abstract

Human natural killer (NK) cells possess an arsenal of receptors programmed to regulate the NK cell functions, once encountering a target cell. In general, the activating receptors mediate cytotoxicity when engaged by their tumor specific, stress induced, virally encoded, or rarely, self ligands. Whereas, the inhibitory receptors bind self molecules, mostly MHC class I, presented on all normal and healthy nucleated cells. However, NK cells also possess numerous, highly homologous, pairs of receptors that sometimes even share the same ligands but display divergent functions. In this review we describe the NK cell repertoire of paired receptors and discuss questions regarding their function and mode of action. We focus primarily on the three PVR-binding receptors; the co-stimulatory DNAM1 and CD96 and the inhibitory TIGIT.
Copyright © 2010 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20828570     DOI: 10.1016/j.febslet.2010.08.047

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering.

Authors:  Katharina F Stengel; Kristin Harden-Bowles; Xin Yu; Lionel Rouge; Jianping Yin; Laëtitia Comps-Agrar; Christian Wiesmann; J Fernando Bazan; Dan L Eaton; Jane L Grogan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

2.  Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells.

Authors:  Venkateswara R Simhadri; John F Andersen; Eric Calvo; Seung-Chul Choi; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

3.  hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.

Authors:  Wen Jiang; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-08       Impact factor: 4.553

4.  The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Authors:  Christopher J Chan; Ludovic Martinet; Susan Gilfillan; Fernando Souza-Fonseca-Guimaraes; Melvyn T Chow; Liam Town; David S Ritchie; Marco Colonna; Daniel M Andrews; Mark J Smyth
Journal:  Nat Immunol       Date:  2014-03-23       Impact factor: 25.606

5.  Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation.

Authors:  Ditsa Levanon; Varda Negreanu; Joseph Lotem; Karen Rae Bone; Ori Brenner; Dena Leshkowitz; Yoram Groner
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

Review 6.  MCMV avoidance of recognition and control by NK cells.

Authors:  Ilija Brizić; Tihana Lenac Roviš; Astrid Krmpotić; Stipan Jonjić
Journal:  Semin Immunopathol       Date:  2014-08-21       Impact factor: 9.623

7.  Gene expression analysis of whole blood, peripheral blood mononuclear cells, and lymphoblastoid cell lines from the Framingham Heart Study.

Authors:  Roby Joehanes; Andrew D Johnson; Jennifer J Barb; Nalini Raghavachari; Poching Liu; Kimberly A Woodhouse; Christopher J O'Donnell; Peter J Munson; Daniel Levy
Journal:  Physiol Genomics       Date:  2011-11-01       Impact factor: 3.107

Review 8.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 9.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

Authors:  Noa Stanietsky; Tihana Lenac Rovis; Ariella Glasner; Einat Seidel; Pinchas Tsukerman; Rachel Yamin; Jonatan Enk; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.